CASSANDRA MANCE: Open Payments
NPI 1649853219 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$89 in 5 payments from 5 companies in 2025. Trend: 2023 $171 · 2024 $137 · 2025 $89
Food & beverage: $89
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: IMFINZI, MONOFERRIC, ALUNBRIG, Itovebi, KEYTRUDA.
Industry payments across OH — which companies pay providers there.
